| Literature DB >> 33718613 |
Omar Moinuddin1, Rebhi O Abuzaitoun1, Min W Hwang1, Sanjana K Sathrasala1, Xing D Chen1, Joshua D Stein1, Mark W Johnson1, David N Zacks1, Thomas J Wubben1, Cagri G Besirli1.
Abstract
OBJECTIVE: To report anatomic and visual outcomes of pars plana vitrectomy (PPV), as well as scleral buckling (SB) and PPV/SB as surgical treatments for the management of primary, non-complex rhegmatogenous retinal detachment (RRD). METHODS AND ANALYSIS: Data from 751 eyes that underwent PPV, SB or combined PPV/SB as a surgical treatment for primary non-complex RRD with at least 3 months of follow-up were analysed to determine rates of single surgery anatomic success (SSAS) and final anatomic success (FAS). Patients or the public were not involved in the design, conduct or reporting of this research.Entities:
Keywords: macula; retina; treatment surgery; vision; vitreous
Year: 2021 PMID: 33718613 PMCID: PMC7908907 DOI: 10.1136/bmjophth-2020-000651
Source DB: PubMed Journal: BMJ Open Ophthalmol ISSN: 2397-3269
Appendix of data extraction codes
| Surgery/Diagnosis | ICD 10 | ICD 9 | CPT |
| H33.00, H33.01, H33.02, H33.001, H33.002, H33.009, H33.011, H33.012, H33.019, H33.021, H33.022, H33.029 | 361.00, 361.01, 361.02, 361.05 | ||
| – | – | 67101, 67 105 | |
| – | – | 67108, 67036, 67039, 67 040 | |
| – | – | 67 107 |
CPT, Current Procedural Terminology; ICD, International Classification of Diseases.
Demographics
| Total (n=751) | PPV (n=668) | PPV/SB (n=51) | SB (n=32) | P value* † | |
| n (%) or median (range) | n (%) or median (range) | n (%) or median (range) | n (%) or median (range) | ||
| 55 (9–92) | 56 (10–92) | 54 (12–74) | 32 (9–83) | <0.001 | |
| 506 (67.4%) | 452 (67.7%) | 32 (62.7%) | 22 (68.8%) | 0.759 | |
| 405 (53.9%) | 362 (54.2%) | 22 (43.1%) | 21 (65.6%) | 0.124 | |
| 22.5 (3–100) | 24 (3–100) | 21 (3–26) | 12 (3–20) | <0.001 |
*P values reflect the comparison between the three surgical groups (PPV, PPV/SB and SB).
†P values <0.05 obtained by ANOVA or χ2 test were considered statistically significant.
ANOVA, analysis of variance; PPV, pars plana vitrectomy; SB, scleral buckling.
Retinal detachment size, location, macular status, location of breaks, number of retinal breaks and lens status at time of surgery
| Total | PPV | PPV/SB | SB | P value* † | |
| n (%) or Median (range) | n (%) or Median (range) | n (%) or Median (range) | n (%) or Median (range) | ||
| 4.8 (1–11) | 4.8 (1–10) | 5.6 (1.5–11) | 4.2 (2–6) | 0.007 | |
| Superior | 385 (56.2%) | 348 (57.3%) | 19 (41.3%) | 18 (56.2%) | 0.313 |
| Inferior | 222 (32.4%) | 192 (31.7%) | 19 (41.3%) | 11 (34.4%) | |
| Equilateral | 78 (11.4%) | 67 (11.0%) | 8 (17.4%) | 3 (9.4%) | |
| On | 335 (44.6%) | 303 (45.4%) | 15 (29.4%) | 17 (53.1%) | 0.53 |
| Off | 416 (55.4%) | 365 (54.6%) | 36 (70.6%) | 15 (46.9%) | |
| Inferior | 297 (39.5%) | 262 (39.2%) | 20 (39.2%) | 15 (46.9%) | 0.687 |
| Non-inferior | 454 (60.5%) | 406 (60.8%) | 31 (60.8%) | 17 (53.1%) | |
| 1 | 293 (40.9%) | 263 (41.4%) | 19 (38.0%) | 11 (36.7%) | 0.124 |
| 2–4 | 208 (29.1%) | 189 (29.7%) | 15 (30.0%) | 4 (13.3%) | |
| >4 | 215 (30.0%) | 184 (28.9%) | 16 (32.0%) | 15 (50.0%) | |
| Phakic | 441 (59.9%) | 378 (57.8%) | 35 (68.6%) | 28 (90.3%) | 0.001 |
| Pseudophakic | 295 (40.1%) | 276 (42.2%) | 16 (31.4%) | 3 (9.7%) | |
*P values reflect the comparison between the three surgical groups (PPV, PPV/SB and SB).
†P values <0.05 obtained by ANOVA or χ2 test were considered statistically significant.
ANOVA, analysis of variance; PPV, pars plana vitrectom; SB, scleral buckling.
Single surgery anatomic success and final anatomic success
| Overall | PPV | PPV/SB | SB | |
| n (%) | n (%) | n (%) | n (%) | |
| Overall | 682/751 (90.8) | 609/668 (91.2) | 43/51 (84.3) | 30/32 (93.8) |
| Macula on | 307/335 (91.6) | 281/303 (92.7) | 11/15 (73.3) | 15/17 (88.2) |
| Macula off | 375/416 (90.1) | 328/365 (89.9) | 32/36 (88.9) | 15/15 (100.0) |
| Inferior breaks | 264/297 (88.9) | 233/262 (88.9) | 17/20 (85.0) | 14/15 (93.3) |
| Non-inferior breaks | 418/454 (92.1) | 376/406 (92.6) | 26/31 (83.9) | 16/17 (94.1) |
| Phakic | 403/441 (91.4) | 349/378 (92.3) | 28/35 (80.0) | 26/28 (92.9) |
| Pseudophakic | 266/295 (90.2) | 248/276 (89.9) | 15/16 (93.8) | 3/3 (100.0) |
| Overall | 726/751 (96.7) | 646/668 (96.7) | 48/51 (94.1) | 32/32 (100.0) |
| Macula-on | 326/335 (97.3) | 295/303 (97.4) | 14/15 (93.3) | 17/17 (100.0) |
| Macula-off | 400/416 (96.2) | 351/365 (96.2) | 34/36 (94.4) | 15/15 (100.0) |
| Inferior breaks | 285/297 (96.0) | 252/262 (96.2) | 18/20 (90.0) | 15/15 (100.0) |
| Non-inferior breaks | 441/454 (97.1) | 394/406 (97.0) | 30/31 (96.8) | 17/17 (100.0) |
| Phakic | 425/441 (96.4) | 364/378 (96.3) | 33/35 (94.3) | 28/28 (100.0) |
| Pseudophakic | 287/295 (97.3) | 269/276 (97.5) | 15/16 (93.8) | 3/3 (100.0) |
FAS, final anatomic success; PPV, pars plana vitrectomy; SB, scleral buckling; SSAS, single surgical anatomic success.
Postoperative visual outcomes (logMAR)
| Overall | PPV | PPV/SB | SB | |
| Median | Median | Median (range) | Median | |
| 0.097 (−0.12 to 5) | 0.097 (−0.12 to 5) | 0.301 (0 to 5) | 0.097 (0 to 3) | |
| 0.097 (−0.12 to 5) | 0.097 (−0.12 to 5) | 0.280 (0 to 4) | 0.000 (0 to 3) | |
| 0.176 (−0.12 to 5) | 0.176 (−0.12 to 5) | 0.301 (0 to 5) | 0.243 (0 to 0.602) | |
| 0.097 (−0.12 to 5) | 0.097 (−0.12 to 5) | 0.097 (0 to 3) | 0.097 (0 to 3) | |
| 0.176 (−0.12 to 5) | 0.097 (−0.12 to 4) | 0.398 (0 to 5) | 0.097 (0 to 0.602) | |
| 0.097 (−0.12 to 5) | 0.097 (−0.12 to 5) | 0.234 (0 to 4) | 0.097 (0 to 3) | |
| 0.097 (−0.12 to 5) | 0.097 (−0.12 to 4) | 0.398 (0 to 5) | 0.176 (0 to 0.477) |
PPV, pars plana vitrectomy; SB, scleral buckling.